Ex parte LEHMANN et al. - Page 6



          Appeal No. 1997-3189                                                        
          Application 08/592,898                                                      

          are exemplified.  However, the fact that many are disclosed would           
          not have made any of them less obvious, particularly where, as              
          here, the formazan dyes recited in appellants’ claim are used for           
          the identical purpose taught by the reference.  See Merck & Co.             
          v. Biocraft Laboratories, Inc., 874 F.2d 804, 807, 10 USPQ2d                
          1843, 1846 (Fed. Cir.), cert. denied, 493 U.S. 975 (1989); In re            
          Lemin, 332 F.2d 839, 841, 141 USPQ 814, 815 (CCPA 1964).                    
               Appellants’ above-noted argument that Geigy ‘464 does not              
          disclose use of the formazan dyes in combination with other dyes            
          is not persuasive because use of such mixtures is disclosed by              
          Balliello (col. 1, lines 53-60).  Appellants’ above-noted                   
          argument that the only metal complex dyes which Geigy ‘464                  
          indicates as being preferable are azo dyes is not convincing                
          because the reference is not limited to its preferred                       
          embodiments.  See In re Kohler, 475 F.2d 651, 653, 177 USPQ 399,            
          400 (CCPA 1973); In re Mills, 470 F.2d 649, 651, 176 USPQ 196,              
          198 (CCPA 1972).  Instead, all disclosures in the reference must            
          be evaluated for what they would have fairly suggested to one of            










Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007